Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastrointestinal Motility and Improves Postprandial Glycemia in Mice

The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders

(2013) Cristoforo Silvestri et al.   Cell Metabolism

Analysis of the “endocannabinoidome” in peripheral tissues of obese Zucker rats

(2013) F.A. Iannotti et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Update on incretin hormones

(2012) Liza K. Phillips et al.   Annals of the New York Academy of Sciences

Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice

(2012) Jie Liu et al.   GASTROENTEROLOGY

AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor

(2011) Daniele Bolognini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: Evidence from cultured explants

(2011) Tony Jourdan et al.   HEPATOLOGY

Cannabinoid Receptor Type 1 (CB1R) Signaling Regulates Hepatic Gluconeogenesis via Induction of Endoplasmic Reticulum-bound Transcription Factor cAMP-responsive Element-binding Protein H (CREBH) in Primary Hepatocytes

(2011) Dipanjan Chanda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Acute Enterocyte Adaptation to Luminal Glucose: A Posttranslational Mechanism for Rapid Apical Recruitment of the Transporter GLUT2

(2011) Rizwan M. Chaudhry et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Mechanisms of glucose uptake in intestinal cell lines: Role of GLUT2

(2011) Ye Zheng et al.   SURGERY

The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice

(2010) Eiichi Ogawa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

CB1 Cannabinoid Receptors and their Associated Proteins

(2010) Allyn Howlett et al.   CURRENT MEDICINAL CHEMISTRY

CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice

(2010) T. Jourdan et al.   DIABETES

The serum D-xylose test as a useful tool to identify malabsorption in rats with antigen specific gut inflammatory reaction

(2009) Danielle Mota Fontes Antunes et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

CB1 antagonists for obesity—what lessons have we learned from rimonabant?

(2009) Vincenzo Di Marzo et al.   Nature Reviews Endocrinology

Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats

(2008) Marnie Duncan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet

(2008) V Di Marzo et al.   BRITISH JOURNAL OF PHARMACOLOGY

Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats

(2008) R. Nogueiras et al.   DIABETES

Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects

(2008) A A Izzo et al.   GUT

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

(2008) Douglas Osei-Hyiaman et al.   JOURNAL OF CLINICAL INVESTIGATION

Gastrointestinal Regulation of Food Intake: General Aspects and Focus on Anandamide and Oleoylethanolamide

(2008) R. Capasso et al.   JOURNAL OF NEUROENDOCRINOLOGY

Lack of a Significant Effect of Cannabinoids upon the Uptake of 2-Deoxy-D-Glucose by Caco-2 Cells

(2008) Pedro Gonçalves et al.   PHARMACOLOGY

Biology of endocannabinoid synthesis system

(2008) Jun Wang et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes

(2008) Helle Linnebjerg et al.   REGULATORY PEPTIDES

Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation

(2007) K L Wright et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endocannabinoids and the gastrointestinal tract: what are the key questions?

(2007) G J Sanger   BRITISH JOURNAL OF PHARMACOLOGY